COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas

Glioma is the most common malignancy of the central nervous system. Although advances in surgical resection, adjuvant radiotherapy, and chemotherapy have been achieved in the last decades, the prognosis of gliomas is still dismal. COL5A1 is one of the collagen members with minor content but prominen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sujie Gu, Zesheng Peng, Yuxi Wu, Yihao Wang, Deqiang Lei, Xiaobing Jiang, Hongyang Zhao, Peng Fu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0cdfcbe515de420083fb0eb4c747a0da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!